LINDSAY HAISLIP: Open Payments
NPI 1275034647 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 40 payments from 4 companies in 2025. Trend: 2023 $168 · 2024 $545 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 24 | $298 |
| ViiV Healthcare Company | 13 | $291 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| PFIZER INC. | 1 | $16 |
Products named: CABENUVA, DOVATO, APRETUDE, PIFELTRO, PREVNAR 20, Biktarvy.
Industry payments across LA — which companies pay providers there.
